View of PPAR-γ AGONIST AS PART OF COMBINATION THERAPY IN PATIENTS WITH METABOLIC SYNDROME: ASSESSMENT OF CLINICAL EFFECTIVENESS | World of Medicine and Biology

← PPAR-γ AGONIST AS PART OF COMBINATION THERAPY IN PATIENTS WITH METABOLIC SYNDROME: ASSESSMENT OF CLINICAL EFFECTIVENESS